Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

TOKYO, Japan, January 28 /PRNewswire/ -- Hoya Corporation today announced its consolidated results for the Third Quarter and Nine Months ended December 31, 2007.

Third Quarter 2007 Highlights

- Net sales increased 48.6% to 147.0 billion yen compared to 98.9 billion yen for the third quarter of 2006.

- Operating income increased 1.1% to 27.5 billion yen compared to 27.2 billion yen for the third quarter of 2006.

- Ordinary income increased 12.0% to 28.1 billion yen compared to 25.1 billion yen for the third quarter of 2006.

- Net income increased 13.2 % to 22.6 billion yen compared to 19.9 billion yen for the third quarter of 2006.

- Net sales and ordinary income posted historical records on quarterly basis.

Nine Months 2007 Highlights

PALM DESERT, California and LONDON, January 28 /PRNewswire/ --

- Huddle.net Extends Power of Social Networks for Work and Play with Embedded Web Office Tools and Desktop Document Access

ABBOTT PARK, Illinois, January 28 /PRNewswire/ --

- Lopinavir/ritonavir tablet is the first and only co-formulated protease inhibitor tablet approved for use in children with HIV

Abbott (NYSE: ABT) announced today that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued a positive opinion recommending approval of a new, lower-strength tablet formulation of the company's leading HIV protease inhibitor, Kaletra(R) (lopinavir/ritonavir). In addition, the CHMP has adopted a positive opinion, in coordination with the World Health Organization (WHO), for Aluvia(R) (lopinavir/ritonavir), the tradename of the same lower-strength tablet formulation in developing countries.

SURREY, England, January 28 /PRNewswire/ --

- GlobalEyes Offers Unparalleled Capabilities for Tracking, Management and Control of Assets, People and Vehicles

Wavetrend Technologies Ltd., a world leader in the deployment of active RFID application solutions, announced today that it is expanding its portfolio of innovative products with the release of GlobalEyes, a revolutionary global tracking solution, incorporating multiple communications and tracking technologies with a software management suite. GlobalEyes is set to revolutionize the way in which assets, people and vehicles are monitored and tracked across the globe. Wavetrend is currently working on several pilot projects within the container logistics and vehicle tracking sectors.

JERUSALEM, Israel, January 28 /PRNewswire/ -- Minicom Advanced Systems Ltd., (http://www.minicom.com) a leading manufacturer of KVM solutions for remote server management (http://www.minicom.com/kvm-remote-support.htm), will be showcasing its unique business model at the IT Partners show in Paris, February 5-6. The show, one of Europe's leading events in IT Distribution is a great opportunity for resellers interested in partnering with Minicom to make it happen.

SCOTTSDALE, Arizona and BRIGHTON, England, January 28 /PRNewswire/ --

- Move Reflects iCrossing's Global Digital Marketing Offering

- Arjo Ghosh Named CEO of iCrossing U.K.

iCrossing (http://www.icrossing.com/), a global digital marketing company, today announced that it has fully integrated Spannerworks, a leading U.K. search and social media agency, into the iCrossing brand.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051130/NYW105LOGO )